secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2026-07-10T20:54:05+00:00
Accession:  0001683168-26-005458
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma settles dispute with former Nora Pharma president for CAD$1.5M
--------------------------------------------------------------------------------

- Company to pay CAD$1.5M (approx US$1.06M) to Malek Chamoun to settle all claims and cross-claims.
- Settlement includes earn-out, bonuses, indemnity in lieu of notice, and expense reimbursement; no admission of liability.
- Chamoun must sell all his Sunshine Biopharma shares within 30 days; non-compete and non-solicitation obligations terminated.
- Mutual releases of all claims; parties agree to confidentiality and non-disparagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/0001683168-26-005458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer